F2R and breast carcinoma: The immunostaining results for HER2-negative human breast cancer tissue samples with anti-PAR1-QDs showed that the PAR1 expression level in cancer cells with a poor prognosis was strongly correlated with the prognosis of HER2-negative breast cancer patients.